William H. Milmoe - 30 May 2025 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Director, 10%+ Owner
Signature
/s/ William H Milmoe
Issuer symbol
INBP
Transactions as of
30 May 2025
Net transactions value
+$4,500
Form type
4
Filing time
30 May 2025, 16:45:48 UTC
Previous filing
29 May 2025
Next filing
04 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Milmoe William H. Director, 10%+ Owner 3299 N.W. 2ND AVENUE, BOCA RATON /s/ William H Milmoe 30 May 2025 0001443194

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBP Common Stock Award $4,500 +50,000 +56% $0.0900 138,667 30 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Disposed to Issuer $0 -50,000 -100% $0.000000 0 30 May 2025 Common Stock 50,000 $0.0900 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
F2 75% of the options became exercisable on June 2, 2015 with 25% becoming exercisable in twelve (12) equal monthly installments beginning on July 2, 2015.